NeoGenomics (NEO) Competitor Comparison
We are evaluating the key criteria listed to compare NeoGenomics (NEO) against its competitors in the Diagnostics & Research industry.
Market Capitalization
29 / 58Gross Profits
30 / 52Total Revenue
26 / 57EBITDA
42 / 56Free Cashflow
40 / 56Quick Ratio
7 / 57Earnings per Share
30 / 56Dividend yield
0 / 9Total Cash
17 / 57Performance 3 years
32 / 58Performance 5 years
32 / 58Performance 10 years
19 / 58Linearity 3 years
34 / 58Linearity 5 years
13 / 58Linearity 10 years
25 / 58Total Rank
27 / 58Dividend Rank
25 / 58Valuation Rank
5 / 58Piotroski Rank
55 / 58Muliplier Rank
25 / 58Performance 10 years - NEO ranking 19 / 58
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.